• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

TCF3/E2A的抑制作用有助于霍奇金淋巴瘤的发生。

Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.

作者信息

Guan Hanfeng, Xie Linka, Wirth Thomas, Ushmorov Alexey

机构信息

Department of Orthopaedic Surgery, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan, China.

Institute of Physiological Chemistry, University of Ulm, Ulm, Germany.

出版信息

Oncotarget. 2016 Jun 14;7(24):36854-36864. doi: 10.18632/oncotarget.9210.

DOI:10.18632/oncotarget.9210
PMID:27166193
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5095044/
Abstract

Although Hodgkin and Reed-Sternberg (HRS) cells of classical Hodgkin lymphoma (cHL) derived from germinal or post germinal B cells, they have lost the B cell phenotype in the process of lymphomagenesis. The phenomenon can be at least partially explained by repression of B-cell-specific transcription factors including TCF3, early B-cell factor 1 (EBF1), SPI1/PU.1, and FOXO1, which are down-regulated by genetic and epigenetic mechanisms. The unique phenotype has been suspected to be advantageous for survival of HRS cells. Ectopic expression of some of these transcription factors (EBF1, PU.1, FOXO1) indeed impaired survival of cHL cells. Here we show that forced expression of TCF3 causes cell death and cell cycle arrest in cHL cell lines. Mechanistically, TCF3 overexpression modulated expression of multiple pro-apoptotic genes including BIK, APAF1, FASLG, BOK, and TNFRSF10A/DR4. We conclude that TCF3 inactivation contributes not only to extinguishing of B cell phenotype but also to cHL oncogenesis.

摘要

尽管经典型霍奇金淋巴瘤(cHL)的霍奇金和里德-斯特恩伯格(HRS)细胞源自生发中心或生发后B细胞,但它们在淋巴瘤发生过程中丧失了B细胞表型。这种现象至少可以部分通过包括TCF3、早期B细胞因子1(EBF1)、SPI1/PU.1和FOXO1在内的B细胞特异性转录因子的抑制来解释,这些转录因子通过遗传和表观遗传机制被下调。这种独特的表型被怀疑对HRS细胞的存活有利。其中一些转录因子(EBF1、PU.1、FOXO1)的异位表达确实损害了cHL细胞的存活。在这里,我们表明强制表达TCF3会导致cHL细胞系中的细胞死亡和细胞周期停滞。从机制上讲,TCF3过表达调节了多个促凋亡基因的表达,包括BIK、APAF1、FASLG、BOK和TNFRSF10A/DR4。我们得出结论,TCF3失活不仅有助于消除B细胞表型,而且有助于cHL的肿瘤发生。

相似文献

1
Repression of TCF3/E2A contributes to Hodgkin lymphomagenesis.TCF3/E2A的抑制作用有助于霍奇金淋巴瘤的发生。
Oncotarget. 2016 Jun 14;7(24):36854-36864. doi: 10.18632/oncotarget.9210.
2
Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.早期 B 细胞因子 1(EBF1)在霍奇金淋巴瘤中的作用。
Leukemia. 2013 Mar;27(3):671-9. doi: 10.1038/leu.2012.280. Epub 2012 Oct 1.
3
Potential role of hypoxia in early stages of Hodgkin lymphoma pathogenesis.缺氧在霍奇金淋巴瘤发病机制早期阶段的潜在作用。
Haematologica. 2015 Oct;100(10):1320-6. doi: 10.3324/haematol.2015.127498. Epub 2015 Jul 9.
4
FOXO1 is a tumor suppressor in classical Hodgkin lymphoma.FOXO1 是经典霍奇金淋巴瘤中的肿瘤抑制因子。
Blood. 2012 Apr 12;119(15):3503-11. doi: 10.1182/blood-2011-09-381905. Epub 2012 Feb 17.
5
Aberrant expression of ID2, a suppressor of B-cell-specific gene expression, in Hodgkin's lymphoma.B细胞特异性基因表达抑制因子ID2在霍奇金淋巴瘤中的异常表达。
Am J Pathol. 2006 Aug;169(2):655-64. doi: 10.2353/ajpath.2006.060020.
6
The early transcription factor GATA-2 is expressed in classical Hodgkin's lymphoma.早期转录因子GATA-2在经典型霍奇金淋巴瘤中表达。
J Pathol. 2004 Dec;204(5):538-45. doi: 10.1002/path.1664.
7
Intrinsic inhibition of transcription factor E2A by HLH proteins ABF-1 and Id2 mediates reprogramming of neoplastic B cells in Hodgkin lymphoma.HLH蛋白ABF-1和Id2对转录因子E2A的内在抑制介导了霍奇金淋巴瘤中肿瘤性B细胞的重编程。
Nat Immunol. 2006 Feb;7(2):207-15. doi: 10.1038/ni1285. Epub 2005 Dec 20.
8
Differential Emu enhancer activity and expression of BOB.1/OBF.1, Oct2, PU.1, and immunoglobulin in reactive B-cell populations, B-cell non-Hodgkin lymphomas, and Hodgkin lymphomas.反应性B细胞群体、B细胞非霍奇金淋巴瘤和霍奇金淋巴瘤中鸸鹋增强子活性差异以及BOB.1/OBF.1、Oct2、PU.1和免疫球蛋白的表达
J Pathol. 2004 Jan;202(1):60-9. doi: 10.1002/path.1485.
9
Loss of B cell identity correlates with loss of B cell-specific transcription factors in Hodgkin/Reed-Sternberg cells of classical Hodgkin lymphoma.在经典型霍奇金淋巴瘤的霍奇金/里德-斯腾伯格细胞中,B细胞特性的丧失与B细胞特异性转录因子的丧失相关。
Oncogene. 2002 Jul 25;21(32):4908-20. doi: 10.1038/sj.onc.1205629.
10
Epigenetic processes play a major role in B-cell-specific gene silencing in classical Hodgkin lymphoma.表观遗传过程在经典型霍奇金淋巴瘤的B细胞特异性基因沉默中起主要作用。
Blood. 2006 Mar 15;107(6):2493-500. doi: 10.1182/blood-2005-09-3765. Epub 2005 Nov 22.

引用本文的文献

1
Individualized dynamic risk assessment and treatment selection for multiple myeloma.多发性骨髓瘤的个体化动态风险评估与治疗选择
Br J Cancer. 2025 Jun;132(10):922-936. doi: 10.1038/s41416-025-02987-6. Epub 2025 Apr 1.
2
Altered Transcriptome Response in PBMCs of Czech Adults Linked to Multiple PFAS Exposure: B Cell Development as a Target of PFAS Immunotoxicity.捷克成年人多氟烷基物质暴露相关的 PBMCs 转录组变化:B 细胞发育作为 PFAS 免疫毒性的靶标。
Environ Sci Technol. 2024 Jan 9;58(1):90-98. doi: 10.1021/acs.est.3c05109. Epub 2023 Dec 19.
3
Discovery of novel predisposing coding and noncoding variants in familial Hodgkin lymphoma.

本文引用的文献

1
FOXO1 repression contributes to block of plasma cell differentiation in classical Hodgkin lymphoma.FOXO1 的抑制导致经典霍奇金淋巴瘤中浆细胞分化受阻。
Blood. 2014 Nov 13;124(20):3118-29. doi: 10.1182/blood-2014-07-590570. Epub 2014 Sep 17.
2
A meta-analysis of Hodgkin lymphoma reveals 19p13.3 TCF3 as a novel susceptibility locus.一项对霍奇金淋巴瘤的荟萃分析显示,19p13.3染色体上的TCF3是一个新的易感基因座。
Nat Commun. 2014 Jun 12;5:3856. doi: 10.1038/ncomms4856.
3
Establishment and maintenance of B cell identity.B细胞身份的建立与维持。
家族性霍奇金淋巴瘤中新的易感编码和非编码变异的发现。
Blood. 2023 Mar 16;141(11):1293-1307. doi: 10.1182/blood.2022016056.
4
Molecular biology of Hodgkin lymphoma.霍奇金淋巴瘤的分子生物学。
Leukemia. 2021 Apr;35(4):968-981. doi: 10.1038/s41375-021-01204-6. Epub 2021 Mar 8.
5
Epstein-Barr virus-associated lymphomas.爱泼斯坦-巴尔病毒相关淋巴瘤
Philos Trans R Soc Lond B Biol Sci. 2017 Oct 19;372(1732). doi: 10.1098/rstb.2016.0271.
Cold Spring Harb Symp Quant Biol. 2013;78:23-30. doi: 10.1101/sqb.2013.78.020057. Epub 2014 Apr 14.
4
The increase in BIK expression following ERK1/2 pathway inhibition is a consequence of G₁ cell-cycle arrest and not a direct effect on BIK protein stability.ERK1/2 通路抑制后 BIK 表达的增加是 G₁ 细胞周期阻滞的结果,而不是对 BIK 蛋白稳定性的直接影响。
Biochem J. 2014 May 1;459(3):513-24. doi: 10.1042/BJ20131346.
5
Decitabine represses translocated MYC oncogene in Burkitt lymphoma.地西他滨抑制伯基特淋巴瘤中的易位 MYC 癌基因。
J Pathol. 2013 Apr;229(5):775-83. doi: 10.1002/path.4164. Epub 2013 Feb 22.
6
Positive intergenic feedback circuitry, involving EBF1 and FOXO1, orchestrates B-cell fate.正基因间反馈回路,涉及 EBF1 和 FOXO1,协调 B 细胞命运。
Proc Natl Acad Sci U S A. 2012 Dec 18;109(51):21028-33. doi: 10.1073/pnas.1211427109. Epub 2012 Dec 4.
7
PU.1 is a potent tumor suppressor in classical Hodgkin lymphoma cells.PU.1 是经典霍奇金淋巴瘤细胞中的一种有效的肿瘤抑制因子。
Blood. 2013 Feb 7;121(6):962-70. doi: 10.1182/blood-2012-05-431429. Epub 2012 Dec 4.
8
Role of early B-cell factor 1 (EBF1) in Hodgkin lymphoma.早期 B 细胞因子 1(EBF1)在霍奇金淋巴瘤中的作用。
Leukemia. 2013 Mar;27(3):671-9. doi: 10.1038/leu.2012.280. Epub 2012 Oct 1.
9
Analyzing primary Hodgkin and Reed-Sternberg cells to capture the molecular and cellular pathogenesis of classical Hodgkin lymphoma.分析原发性霍奇金和里德-斯特恩伯格细胞,以捕获经典霍奇金淋巴瘤的分子和细胞发病机制。
Blood. 2012 Nov 29;120(23):4609-20. doi: 10.1182/blood-2012-05-428896. Epub 2012 Sep 5.
10
A differentiation checkpoint limits hematopoietic stem cell self-renewal in response to DNA damage.分化检查点限制造血干细胞在应对 DNA 损伤时的自我更新。
Cell. 2012 Mar 2;148(5):1001-14. doi: 10.1016/j.cell.2012.01.040.